ANTIBODIES

CancerTools.org: The home for cancer research tools

Back

Anti-TLV

Cat. #158068

Tool name: Anti-TLV
Tool type: Antibodies
Class: Polyclonal
Conjugate: Unconjugated
Reactivity: Virus
Host: Rabbit
Molecular weight of the target: 38
Application: ELISA
Description: Tilapia lake virus (TiLV) is an enveloped, negative-sense, single-stranded RNA virus. TiLV appears to cause disease mainly in tilapia and tilapia hybrids (Oreochromis spp., Tilapia spp.), but has also been detected causing disease in other wild cichlids (Sarotherodon galilaeus, Tristramella spp.). This virus is found to be transmitted through direct horizontal transmission by cohabitation or transfer of live aquatic animals. Clinical signs of virus include behavioral changes, skin damage such as erosion, discolouration, skin hemorrhages and loss of scales, eyeball protrusion (exophthalmia) and abdominal swelling. There are currently no treatment or vaccines for TiLV. As the spread of TiLV has global impact in both commercial and ecological settings, anti-TLV can be a useful tool for virus detecting and further application such as disease prevention, treatment monitor and vaccine development. The antibody is a valuable research tool TiLV diagnostics, epidemiological monitoring and vaccine development.
Immunogen: Ovalbumin-conjugated synthetic peptide.
Research area: Cell biology; Immunology

Target: Tilapia Lake Virus
Target molecular weight: 38
Target background: Tilapia lake virus (TiLV) is an enveloped, negative-sense, single-stranded RNA virus. TiLV appears to cause disease mainly in tilapia and tilapia hybrids (Oreochromis spp., Tilapia spp.), but has also been detected causing disease in other wild cichlids (Sarotherodon galilaeus, Tristramella spp.). This virus is found to be transmitted through direct horizontal transmission by cohabitation or transfer of live aquatic animals. Clinical signs of virus include behavioral changes, skin damage such as erosion, discolouration, skin hemorrhages and loss of scales, eyeball protrusion (exophthalmia) and abdominal swelling. There are currently no treatment or vaccines for TiLV. As the spread of TiLV has global impact in both commercial and ecological settings, anti-TLV can be a useful tool for virus detecting and further application such as disease prevention, treatment monitor and vaccine development. The antibody is a valuable research tool TiLV diagnostics, epidemiological monitoring and vaccine development.

£ 300
This fee is applicable only for non-profit organizations

Quantity:

For any enquiries, please, contact us .